Fibroblasts from vimentin-deficient mouse exhibited a reduction in cell motility, defects in directionality and on their ability to organise collagen [25,55], while vimentin overexpression caused increased cell motility of breast cancer cells [56]. This evidence concerns the gene VIM and breast carcinoma.